在质瘤中SEPN1的综合性分析:预后作用,功能影响和潜在的治疗干预措施
Zisong Wang1, Danwen Wang2, Xuanyu Wang1
1Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China.
PloS one
|February 7, 2025
概括
在质瘤中,SEPN1被上调,与预后不佳有关,并且是一个潜在的治疗点. 这种单蛋白是单蛋白.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- SEPN1 (蛋白N) 在氧化还原调节和ER应激中发挥作用.
- 它在癌症,特别是质瘤中的作用仍然基本不明.
- 这项研究研究了SEPN1的泛癌表达,预后价值和瘤微环境 (TME) 的相关性.
研究的目的:
- 阐明SEPN1在胰腺癌中的作用,重点关注质瘤.
- 评估SEPN1的预后意义和TME在质瘤中的相互作用.
- 确定潜在的治疗策略,针对质瘤中的SEPN1.
主要方法:
- 使用TCGA泛癌队列用于SEPN1表达和预后分析.
- 综合TCGA,CGGA,GEO和ZN-GC数据用于深入的质瘤分析.
- 进行了生存分析,单细胞RNA测序,丰富分析,并制定了与SEPN1相关的风险评分 (SRS).
主要成果:
- 在质瘤中,SEPN1被上调,与预后不佳相关,并作为一个独立的风险因素.
- 抑制SEPN1抑制了质母细胞瘤细胞增殖和诱导的亡.
- 该SRS显示出强大的预后价值,并与质瘤TME中免疫透率的增加有关.
结论:
- SEPN1是显著的生物标志物和潜在的治疗质瘤的目标.
- 这些发现支持开发用于质瘤治疗的SEPN1向疗法.
- 在质瘤TME中SEPN1的作用为治疗干预提供了新的途径.
更多相关视频
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.3K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...